Epidemiological Investigation of Helicobacter Pylori-infected Patients and the Effect of Eradication Treatment on Dyspepsia Symptoms

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorShanghai Jiao Tong University School of Medicine

About this trial

The objectives of this multicenter, prospective, observational study were to investigate the incidence of dyspeptic symptoms in patients with Helicobacter pylori (H. pylori) infection and to continuously follow up the remission of dyspeptic symptoms after H. pylori eradication, so as to provide reference for the clinical diagnosis and treatment strategies of patients with H. pylori infection and dyspeptic symptoms.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Male or female patients aged 18-80 years

H. pylori infection diagnosed by 13C/ 14C-UBT (> 2 times the cutoff value) and/or gastroscopy (rapid urease strong positive and histological positive)

Treatment-naive patients with Helicobacter pylori

Ability and willingness to participate in the study and to sign and give informed consent

Disqualifiers

Under 18 or over 80 years old

Organic digestive diseases, such as active peptic ulcer, gastroesophageal reflux, gastrointestinal bleeding, acute/chronic pancreatitis, acute/chronic cholecystitis, gallstones, intestinal obstruction, inflammatory bowel disease, etc.

Combined with melena, hematemesis, anemia, emaciation and other alarm symptoms

Pregnant and lactating women

Trial population

The study population targets male and female patients aged 15-80 who have not previously been treated for Helicobacter pylori and have been diagnosed via 13C/14C urea breath test or gastroscopy. Participants must be willing and able to give informed consent. Exclusions include individuals under 18 or over 80, those with organic digestive diseases, pregnant or nursing women, those with a history of cancer or partial gastrectomy, and individuals with severe organ dysfunction or congenital diseases. Also excluded are those with symptoms like melena, hematemesis, anemia, or cachexia.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Epidemiological questionnaire and Functional Dyspepsia Symptom Diary(FDSD)

    Other intervention

    H. pylori infection was confirmed by 13C/ 14C-breath test and/or rapid urease test under endoscopy and histopathological examination. Epidemiological questionnaire and Functional Dyspepsia Symptom Diary (FDSD) were used to investigate basic information and assess dyspeptic symptoms. Patients with dyspepsia who successfully eradicated Helicobacter pylori infection will be followed up for dyspeptic symptoms after 2 months and 6 months to evaluate the relief of dyspeptic symptoms.

Treatment groups

2,242 Participants
are divided into 1 treatment group
Group A: Dyspepsia with Helicobacter pylori infection1 intervention

Trial outcomes

Primary outcomes

1

the incidence of dyspepsia in patients with Helicobacter pylori infection

Proportion of patients with Helicobacter pylori infection with dyspeptic symptoms

Time frame
Time 0 when finished the Epidemiological questionnaire and Functional Dyspepsia Symptom Diary
2

Relief of Helicobacter pylori related dyspepsia

The Functional Dyspepsia Symptom Diary (FDSD) will be used to evaluate the dyspepsia symptoms of the patients

Time frame
Patients with dyspepsia who have successfully eradicated Helicobacter pylori infection will be followed up for dyspepsia symptoms after 2 months and after 6 months to assess the remission of dyspepsia symptoms

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.